Following total hip replacement, septic hip arthritis linked to higher risk of periprosthetic joint infection

Written By :  Dr. Kamal Kant Kohli
Published On 2022-11-27 14:30 GMT   |   Update On 2022-11-28 05:43 GMT
Advertisement

BALTIMORE: According to a study that was published in The Journal of Arthroplasty, there is a substantial risk of periprosthetic joint infection post total hip arthroplasty if there has been less than a one-year interval of quiescence following septic arthritis of the hip.

Each year, 20,000 people are given the diagnosis of septic arthritis, with 15% of those cases especially impacting the hip joint. These circumstances aggravate arthritic changes, frequently necessitating a total hip replacement (THA). These patients are more likely to develop periprosthetic joint infections as a result of their past infection history (PJIs).

Advertisement

The authors aimed to compare a group of THA patients without a history of septic hip to individuals who were diagnosed with septic hip arthritis at intervals (0 to 6, or 6 to 12 months) before an ipsilateral initial THA. They specifically evaluated (1) PJI-related changes from 90 days to 2 years and (2) risk variables for PJI at 2 years.

For this objective, A national, all-payer database was searched to find all patients who underwent a primary THA between 2010 and 2021, and patients who had previously experienced ipsilateral septic hip arthritis were identified (n = 1,052) using codes from the International Classification of Disease and Current Practice Terminology. As a non-septic group comparison, a randomized sample of patients (n = 5000) who had never previously experienced septic arthritis was used. The occurrences of PJI at 90 days through two years were then determined and compared using bivariate chi-square analysis. Multivariate regression models were then used to examine risk factors for post-THA PJIs.

Conclusive highlights of the study:

  • At 90 days, a year, and two years (all p <0.0001), the cohorts with septic arthritis were more likely than the non-septic group to need modifications as a result of PJIs.
  • In comparison to patients who had diagnoses between 6 and 12 months prior to THA, patients who had septic arthritis diagnoses between 0 and 6 months prior to THA had a higher risk of developing PJI at both one and two years (odds ratio (OR) of 43.1 versus 29.6, p<0.0001 and OR of 38.3 versus 22.1, p<0.0001).
  • In comparison to the population without a history of septic hip, diabetes mellitus, obesity, and cigarette use were linked risk factors for PJIs at 2-years in the cohort with a septic hip.

The authors came to the conclusion that, between 0 and 6 months and between 6 and 12 months, respectively, a shorter than 1-year quiescent period following septic arthritis is linked with a 38- and 22-fold greater risk for post-THA PJI, respectively. Although the risks are lower for patients who undergo THA more than 6 months after their septic arthritis treatment than for those who do so between 0 and 6 months after treatment, they are still substantial.

Orthopaedic surgeons should be mindful of the elevated risks of PJIs when considering a THA in patients with a history of septic arthritis.

REFERENCE

Jeremy A. Dubin et.al., Less than 1-year quiescent period after septic arthritis of the hip is associated with high risk of periprosthetic joint infection following total hip arthroplasty. November 24, 2022 DOI:https://doi.org/10.1016/j.arth.2022.11.004

 

Tags:    
Article Source : The Journal of Arthroplasty

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News